Criticism erupted after the NIH announced scaled-down funding for mRNA vaccine development, citing a lack of public trust. Critics, including former NIH director Jeremy Berg, blame individuals like Jay Bhattacharya, a Trump administration official, for undermining public health institutions and vaccine confidence. Bhattacharya, in a Washington Post op-ed, defended the funding cuts, arguing the vaccines failed to earn public trust despite their success in preventing severe Covid-19. Experts like Paul Offit counter that the vaccines' effectiveness and safety are paramount, not public opinion. The decision raises concerns about potential political influence and a chilling effect on mRNA research.

Prepared by Olivia Bennett and reviewed by editorial team.